- Case report
- Open Access
- Open Peer Review
Aortic aneurysm rupture as a rare complication of granulomatosis with polyangiitis: a case report
© Ohta et al.; licensee BioMed Central Ltd. 2013
- Received: 11 December 2012
- Accepted: 5 March 2013
- Published: 26 July 2013
Granulomatosis with polyangiitis is characterized by systemic inflammation of medium and small blood vessels. Aortic involvement in granulomatosis with polyangiitis is extremely rare. As far as we know this is the first reported case of successful treatment in a patient with granulomatosis with polyangiitis complicated with aortic aneurysm rupture.
We describe a case of granulomatosis with polyangiitis in a 38-year-old Japanese man who developed an aortic aneurysm rupture 22 years after disease onset. The patient was operated on and a J-graft was inserted. He recovered uneventfully.
Recommendations in regard to, and consideration of, aortic involvement should be kept in mind in the long-term careful follow up of granulomatosis with polyangiitis.
- Aortic aneurysm
- Wegener’s granulomatosis
Cases of aortic involvement in granulomatosis with polyangiitis
Duration of complaint
Although GPA is characterized by a systemic necrotizing inflammation of the medium and small arteries, aortic involvement is very uncommon. In general, aortic involvement is more frequently seen in large-vessel vasculitides such as those seen in giant cell arteritis and Takayasu’s arteritis [1–4]. GPA can affect the respiratory and renal tracts. It can also affect the eyes, skin, and peripheral nerves. Non-specific systemic symptoms are common. GPA causes upper respiratory tract disease in >90% of cases and causes sinusitis, nasal crusting, bleeding, and obstruction, and collapse of the nasal bridge [5–8]. It can also cause otitis media and tracheal stenosis. When the lungs are affected, it may present as cough, hemoptysis, and dyspnea. Renal involvement may manifest as hematuria and proteinuria and can lead to renal failure. Ophthalmological manifestations include subconjunctival hemorrhage, scleritis, uveitis, keratitis, proptosis, or ocular muscle paralysis due to retro-orbital inflammation. Serology is positive for anti-proteinase 3 (anti-neutrophil cytoplasmic antibody), which is highly specific for GPA. The differential diagnosis of GPA includes polyarteritis nodosa, Churg–Strauss syndrome, Henoch–Schönlein purpura, temporal arteritis, and Takayasu’s arteritis. The main treatment is immunosuppression and steroid therapy. A combination of cyclophosphamide and prednisone is effective. Our patient had been receiving prednisolone (15mg/day) for 11 years (since his diagnosis) and had remained negative for anti-neutrophil cytoplasmic antibody until he presented with the aneurysm.
Aortic aneurysm is a very rare complication of GPA. To the best of our knowledge, nine other cases of aneurysm of large vessels as a result of GPA have been described [5–15] and this is the first reported case of successful treatment in a patient with GPA complicated with aortic aneurysm rupture. In five of the cases, the patients were operated on and surgical tissue biopsies showed signs of vasculitis indicative of GPA. In one case, the patient was treated with steroids and cyclophosphamide, but medical treatment could not prevent aortic dissection and the patient died from rupture of the dissection. In three cases, the patients were treated medically with drugs that included methylprednisolone and trimethoprim-sulfamethoxazole. CT is an extremely accurate tool for both diagnosis and sizing of aortic aneurysms [5–9]. A longitudinal cohort study of GPA patients evaluated at the U.S. National Institutes of Health between 1968 and 1992 demonstrated that 91% experienced clinical improvement and 75% entered complete remission when treated with cyclophosphamide and methylprednisolone . A meta-analysis revealed that pulse cyclophosphamide is less toxic than continuous cyclophosphamide but may be associated with a higher relapse rate .
In summary, chest pain occurring during a GPA flare may result from aortic involvement and may cause a life-threatening aneurysm rupture for which surgical treatment is indicated. Therefore, aortic involvement should be kept in mind as a potential fatal complication of GPA.
We presented an extremely rare case of thoracic aortic aneurysm rupture as a complication of GPA. GPA should be included in the workup of large-vessel vasculitis, which can give rise to potentially life-threatening periaortic inflammation.
Written informed consent was obtained from the patient for publication of this manuscript and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Ohta N, Fukase S, Aoyagi M: Serum levels of soluble adhesion molecules ICAM-1, VCAM-1 and E-selectin in patients with Wegener’s granulomatosis. Auris Nasus Larynx. 2001, 28: 311-314. 10.1016/S0385-8146(01)00097-9.View ArticlePubMedGoogle Scholar
- Ohta N, Fukase S, Fuse T, Aoyagi M: Th1 and Th2 CD4 T cells and Tc1 and Tc2 CD8 T cells of patients with Wegener’s granulomatosis. J Laryngol Otol. 2002, 116: 605-609.View ArticlePubMedGoogle Scholar
- Ohta N, Fukase S, Aoyagi M: Th1, Th2, Tc1 and Tc2 cells of patients with otolaryngological diseases. Allergol Int. 2004, 53: 199-203. 10.1111/j.1440-1592.2004.00335.x.View ArticleGoogle Scholar
- Yoshitake H, Nitto T, Ohta N, Fukase S, Aoyagi M, Sendo F, Araki Y: Elevation of the soluble form GPI-80, a b2 integrin-associated glycosylphosphatidylinositol anchored protein in the serum of patients with Wegener’s granulomatosis. Allergol Int. 2005, 54: 299-303. 10.2332/allergolint.54.299.View ArticleGoogle Scholar
- Minnee RC, van den Berk GE, Groeneveld JO, van Dijk J, Turkcan K, Visser MJ, Vahl AC: Aortic aneurysm and orchitis due to Wegener’s granulomatosis. Ann Vasc Surg. 2009, 23: 786.e15-e19. 10.1016/j.avsg.2009.06.011.View ArticleGoogle Scholar
- Fink AM, Miles KA, Wraight EP: Indium-111 labelled leukocyte uptake in aortitis. Clin Radiol. 1994, 49: 863-866. 10.1016/S0009-9260(05)82876-4.View ArticlePubMedGoogle Scholar
- Durai R, Agrawal R, Piper K, Brohi K: Wegener’s granulomatosis presenting as an abdominal aortic aneurysm: a case report. Cases J. 2009, 2: 9346-10.1186/1757-1626-2-9346.View ArticlePubMedPubMed CentralGoogle Scholar
- Blockmans D, Baeyens H, Van Loon R, Lauwers G, Bobbaers H: Periaortitis and aortic dissection due to Wegener’s granulomatosis. Clin Rheumatol. 2000, 19: 161-164. 10.1007/s100670050038.View ArticlePubMedGoogle Scholar
- Carels T, Verbeken E, Blockmans D: p-ANCA-associated periaortitis with histological proof of Wegener’s granulomatosis: case report. Clin Rheumatol. 2005, 24: 83-86. 10.1007/s10067-004-0998-0.View ArticlePubMedGoogle Scholar
- Chirinos JA, Tamariz LJ, Lopes G, Del Carpio F, Zhang X, Milikowski C, Lichtsein DM: Large vessel involvement in ANCA-associated vasculitides: report of a case and review of literature. Clin Rheumatol. 2004, 23: 152-159. 10.1007/s10067-003-0816-0.View ArticlePubMedGoogle Scholar
- Unlu C, Willems M, Ten Berge IJM, Legemate DA: Aortitis with aneurysm formation as a rare complication of Wegener’s granulomatosis. J Vasc Surg. 2011, 54: 1485-1487. 10.1016/j.jvs.2011.05.014.View ArticlePubMedGoogle Scholar
- Arlet JB, Le Thi HD, Marinho A, Cluzel P, Wechsler B, Piette JC: Arterial aneurysms in Wegener’s granulomatosis: case report and literature review. Semin Arthritis Rheum. 2008, 37: 265-268. 10.1016/j.semarthrit.2007.07.004.View ArticlePubMedGoogle Scholar
- Polverosi R, Ciltton O, Vigo M, Cantone A, Scapinetto A: Abdominal aortic aneurysm in Wegener’s granulomatosis and subsequent thoracic involvement. Report of a case. Radiol Med. 1999, 96: 101-102.Google Scholar
- Bartella L, McHugh K, Dillon MJ: Ascending aortic aneurysm in a boy with vasculitis. Pediatr Radiol. 2001, 3: 675-View ArticleGoogle Scholar
- Sieber SC, Cvello B, Gelfman NA, Garfinkel HB: Pulmonary capillaritis and glomerulonephritis in an antineutrophil cytoplasmic antibody-positive patient with prior granulomatous aortitis. Arch Pathol Lab Med. 1990, 114: 1223-1226.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.